CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
Clinical trial NCT05440786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05440786
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2025-01-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.